BridgeBio Oncology Therapeutics, Inc recently revealed that the eagerly awaited updated data from its Phase I clinical trial is expected to be released in the second half of 2026.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The announcement of this timeline provides clear expectations for investors and industry observers following the company's R&D progress. This data update is crucial for assessing the safety and preliminary efficacy of the relevant candidate drugs. The latest developments in the company's R&D pipeline may influence its future clinical development strategy and market positioning.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Coldcard exploit reveals years-long Bitcoin theft campaign — Details
AMBCrypto•2026/08/18 05:33
Basilea publishes investor presentation on anti-infectives strategy and pipeline progress
Reuters•2026/08/18 05:27
Braskem Idesa files Chapter 11 to cut senior debt by more than US$920 million
Reuters•2026/08/18 05:17
Basilea H1 FY26 profit rises 76.6% to CHF 27.9 million; revenue climbs 14.4% to CHF 119 million
Reuters•2026/08/18 05:15
Crypto prices
More
Bitcoin
BTC
$64,151.42
+0.98%
Ethereum
ETH
$1,894.33
-0.40%
Tether USDt
USDT
$0.9990
-0.00%
USDC
USDC
$0.9998
-0.00%
XRP
XRP
$0.9956
-0.68%
Solana
SOL
$75.83
+0.44%
TRON
TRX
$0.3316
-0.17%
Hyperliquid
HYPE
$59.38
+0.87%
Dogecoin
DOGE
$0.06986
-0.45%
Zcash
ZEC
$510.56
+3.76%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now